Literature DB >> 7994967

Relationship between osteofibrous dysplasia and adamantinoma.

D S Springfield1, A E Rosenberg, H J Mankin, E R Mindell.   

Abstract

The records and computer files of 32 patients treated at 1 institution for ossifying fibroma, fibrous dysplasia, osteofibrous dysplasia-like adamantinoma, or adamantinoma of the tibia were reviewed. Nineteen patients had their diagnosis changed, either because of a recurrence or through review of their histology. Six of the 9 patients who had a typical adamantinoma and 6 of the 10 patients who had an osteofibrous dysplasia-like adamantinoma had a diagnosis of 1 of the benign conditions before their adamantinoma was recognized. Only 6 patients actually had osteofibrous dysplasia. Three patients required a resection, but only 1 of the other 3 has been observed > 5 years. This review suggests that many patients with a diagnosis of fibrous dysplasia or osteofibrous dysplasia of the tibia actually have an adamantinoma, and that osteofibrous dysplasia is often a locally aggressive lesion that progresses until it is widely resected. In addition, osteofibrous dysplasia and adamantinoma appear to be related, and osteofibrous dysplasia may be a precursor of adamantinoma.

Entities:  

Mesh:

Year:  1994        PMID: 7994967

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  15 in total

1.  Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia.

Authors:  Takeshi G Kashima; Arunthati Dongre; Adrienne M Flanagan; Pancras C W Hogendoorn; Richard Taylor; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2011-04-16       Impact factor: 4.064

2.  Bilateral Symmetric Sporadic Osteofibrous Dysplasia: an Unusual Case.

Authors:  Asit Ranjan Mridha; Anubhav Narwal; Adarsh Barwad; Venkatesan Sampat Kumar; Shivanand Gamanagatti; Prashant Ramteke
Journal:  Indian J Surg Oncol       Date:  2020-10-08

3.  p63 expression in adamantinoma.

Authors:  Brendan C Dickson; Yair Gortzak; Robert S Bell; Peter C Ferguson; David J C Howarth; Jay S Wunder; Rita A Kandel
Journal:  Virchows Arch       Date:  2011-06-15       Impact factor: 4.064

4.  [Osteofibrous dysplasia campanacci of the tibia. A 12-year follow-up].

Authors:  M Napp; B-A Stengel; J Buschmann; J R Döhler
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

5.  Adamantinoma: an unusual bone tumour.

Authors:  Pedro Roque; Henry J Mankin; Andrew Rosenberg
Journal:  Chir Organi Mov       Date:  2008-11-15

6.  MR findings of the osteofibrous dysplasia.

Authors:  Joon-Yong Jung; Won-Hee Jee; Sung Hwan Hong; Heung Sik Kang; Hye Won Chung; Kyung-Nam Ryu; Jee-Young Kim; Soo-A Im; Jeong-Mi Park; Mi-Sook Sung; Yeon-Soo Lee; Suk-Joo Hong; Chan-Kwon Jung; Yang-Guk Chung
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

7.  DNA aberrations in the epithelial cell component of adamantinoma of long bones.

Authors:  H M Hazelbag; G J Fleuren; C J Cornelisse; L J van den Broek; A H Taminiau; P C Hogendoorn
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

8.  Treatment of osteofibrous dysplasia and associated lesions.

Authors:  Soo Bong Hahn; Sung Hun Kim; Nam Hoon Cho; Chul Jun Choi; Bom Soo Kim; Ho Jung Kang
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

9.  Adamantinoma: a clinicopathological review and update.

Authors:  Deepali Jain; Vijay K Jain; Rakesh K Vasishta; Prabhat Ranjan; Yashwant Kumar
Journal:  Diagn Pathol       Date:  2008-02-15       Impact factor: 2.644

10.  Metastatic or metachronous adamantinoma: An Enigma.

Authors:  As Ramaswamy; Kr Chatura; Hr Chandrasekhar
Journal:  Int J Appl Basic Med Res       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.